Rachel E. Crossland
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
Papers in
-
- MicroRNA in disease regulation 14
-
- Hematopoietic Stem Cell Transplantation 8
- Co-authors
- Anne Mary Dickinson (20 shared papers)Jean Norden (10 shared papers)Hildegard Greinix (8 shared papers)Vikki Rand (4 shared papers)Chris M. Bacon (4 shared papers)Mateja Kralj Juric (5 shared papers)Despina Televantou (2 shared papers)Kim Frances Pearce (5 shared papers)
- Journals
- Frontiers in Immunology (13 papers)Blood (4 papers)International Journal of Molecular Sciences (2 papers)Journal of Immunological Methods (1 paper)Disease Markers (1 paper)
- Partner nations
- United KingdomAustriaPoland
In The Last Decade
Rachel E. Crossland
34 papers receiving 588 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 250
- Hematology 112
- Genetics 69
- Transplantation 13
- Immunology 94
Countries citing papers authored by Rachel E. Crossland
This map shows the geographic impact of Rachel E. Crossland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Crossland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Crossland more than expected).
Fields of papers citing papers by Rachel E. Crossland
This network shows the impact of papers produced by Rachel E. Crossland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Crossland. The network helps show where Rachel E. Crossland may publish in the future.
Co-authors
The 25 scholars most cited alongside Rachel E. Crossland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 136 | |
| 2 | 2015 | 71 | |
| 3 | 2021 | 33 | |
| 4 | 2017 | 32 | |
| 5 | 2017 | 31 | |
| 6 | 2018 | 23 | |
| 7 | 2014 | 22 | |
| 8 | 2016 | 22 | |
| 9 | 2020 | 21 | |
| 10 | 2017 | 17 | |
| 11 | 2018 | 17 | |
| 12 | 2023 | 17 | |
| 13 | 2021 | 15 | |
| 14 | 2020 | 14 | |
| 15 | 2022 | 14 | |
| 16 | 2021 | 12 | |
| 17 | 2021 | 12 | |
| 18 | 2023 | 12 | |
| 19 | 2023 | 12 | |
| 20 | 2017 | 11 |
About Rachel E. Crossland
Rachel E. Crossland is a scholar working on Cancer Research, Hematology, Genetics, Molecular Biology and Immunology, having authored 36 papers that have together received 592 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (20 papers), MicroRNA in disease regulation (14 papers), Hematopoietic Stem Cell Transplantation (8 papers), Mesenchymal stem cell research (7 papers), T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (5 papers), Bone and Joint Diseases (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (250 citations), Hematology (112 citations), Genetics (69 citations), Transplantation (13 citations) and Immunology (94 citations). Rachel E. Crossland has collaborated with scholars based in United Kingdom, Austria and Poland. Frequent co-authors include Anne Mary Dickinson, Jean Norden, Hildegard Greinix, Vikki Rand, Chris M. Bacon, Mateja Kralj Juric, Despina Televantou, Kim Frances Pearce, Simon N. Bomken and Clare Lendrem. Their work appears in journals such as Frontiers in Immunology, Blood, International Journal of Molecular Sciences, Journal of Immunological Methods and Disease Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.